Victor S. Sloan

Mediation by HLA-DM of dissociation of peptides from HLA-DR

Victor S. Sloan, Patricia M. Cameron, Gene Porter et al. · Nature · 1995 · 543 citations

Protein Folding, Peptide Library, Biochemistry +1

Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases

Georg Schett, Victor S. Sloan, Randall M. Stevens et al. · Therapeutic Advances in Musculoskeletal Disease · 2010 · 163 citations · Full text

Phosphodiesterase 4, Immunology, Cell Death +21

Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis

Stephen Jarrett, Philip G. Conaghan, Victor S. Sloan et al. · Arthritis & Rheumatism · 2006 · 152 citations

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

R. Lehmann, Marek Brzosko, Petr Kopsa et al. · Current Medical Research and Opinion · 2005 · 73 citations

Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo

Eric Sheldon, André Beaulieu, Zorba Paster et al. · Clinical Therapeutics · 2005 · 63 citations

Medicine, Chronic Musculoskeletal Condition, Osteoarthritis +6